Skyclarys 50 mg, Hartkapseln

7680696100012 CH-69610 Kapseln
Skyclarys 50 mg, Hartkapseln
Skyclarys 50 mg, Hartkapseln
1 / 2
google

Article details

Package size
90
Selling units
90
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
25/07/2026
Summary of Product Characteristics
Français
25/07/2026
Summary of Product Characteristics
Italien
25/07/2026
Patient information leaflet
Allemand
18/02/2026
Patient information leaflet
Français
18/02/2026
Patient information leaflet
Italien
18/02/2026

Detailed composition

Substance Quantity Type Category
omaveloxolonum
50.0 MG Substance Wirkstoff (Principe actif)
amylum pregelificatum
- Substance HNIDK
cellulosum microcristallinum silicificatum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
E 133
- Substance FIMDK
E 172 (flavum)
- Substance FTODK
lacca
- Substance HNIDK
E 171
- Substance FNIDK
natrium
- Substance HBESI

Reimbursement information

Public price
CHF 21395.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2025

Authorization holder

Biogen Switzerland AG

6340 Baar

Authorization information

Swissmedic authorization number
69610
Drug name
Skyclarys, Hartkapseln
Galenic form
KAHA
ATC Code
N07XX25
Authorization status
Z
Dispensing category
B
First authorization
24/09/2024
Authorization expiration date
23/09/2029
IT Number
01.99.0.
Domain
Human medicine
Field of application
Behandlung der Friedreich-Ataxie

Package details

Description (FR)
SKYCLARYS caps 50 mg bte 90 pce
Description (DE)
SKYCLARYS Kaps 50 mg Ds 90 Stk
Market launch
24/09/2024
Narcotic (BTM)
No

Other package sizes (1)

None
270 (3 x 90) KAP
GTIN: None
Not in V1
Buy us a coffee Explore the data